Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06184633 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DUTCH Weight Control in Atrial Fibrillation Study

Study acronym: DUTCH-WAIST
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later May 1, 2026 → Apr 10, 2027
See other at-risk trials from Rijnstate Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 1, 2026 to Apr 10, 2027 Show 6 more changesShow less
    • Enrollment closed, study ongoing
    • Trial sites expanded: 1 → 20 locations
    • Interventions: Placebo (Drug), Semaglutide 3.2 MG/ML (Drug) to Placebo (Drug), Semaglutide 3.2 MG/ML (Drug)
    • Eligibility criteria expanded, about 23 words
    • Secondary endpoints: details revised at 3 of 11 entries
    • Study description expanded, about 8 words
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of May 1, 2024 to Jul 21, 2024
    v3
  3. Minor Secondary endpoints revised (11)v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
8,786 trials monitored
See 412 trials at risk
3,874 trials monitored
See 152 trials at risk
Quantify the effect of an innovative weight loss management on rhythm control.
Trial Details
NCT Number NCT06184633
Lead Sponsor Rijnstate Hospital
Conditions
(from sponsor)
Atrial Fibrillation, Obesity, Weight Loss
Related terms Atrial Fibrillation, Obesity, Weight Loss
Enrollment 280 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov